Tetra Bio-Pharma, Targeted Pharmaceutical & the George Mason University Partner on ARDS-003 to Prevent & Treat COVID-19

Published : 24 Oct 2020

Drug Name: PPP-003

Tetra Bio-Pharma inc., a pacesetter in cannabinoid-derived drug discovery and development, is worked up to announce that it's signed a research collaboration agreement with Targeted Pharmaceutical and therefore the American Revolutionary leader University NCBID. As antecedently disclosed half-moon, characin formally nonheritable a 2 hundredth minority stake in Targeted Pharmaceutical. As per the Officer Certificate provided to the TSX, Targeted complies with all applicable laws within the jurisdictions during which they operate.

The NCBI may be a leading institute conducting pioneering analysis on infectious diseases as well as diagnostic, medical specialty, and immunogen development. The analysis collaboration can permit the analysis of ARDS-003, with and while not antiviral medication, to stop and treat SARS-CoV-2 infection in animals.

Under the leadership of Dr. Lance Liotta, Chief medic at Targeted medical specialty, and faculty member at the American Revolutionary leader University, ARDS-003 are going to be studied in SARS-CoV-2 infected animals to additional perceive its potential as a preventive and therapeutic medication. This analysis is going to be performed by Dr. Liotta's team at the Biocontainment Laboratory-George Mason University NCBID. Dr. Liotta has served as Co-Director and Co-Founder of the middle for Applied genetic science and Molecular medication (CAPMM) at the American Revolutionary leader University. before this appointment, Dr. Liotta served as Chief of the Laboratory of Pathology, NCI, Deputy Director of a government agency, Co-Director of the NCI/FDA Clinical genetic science Program, and Director of the Anatomic Pathology Residency Program.

Dr. Guy Chamberland, chief executive officer, and cathode-ray oscilloscope commented, "We have initiated this analysis agreement to get new belongings and work nearer with key researchers within the USA World Health Organization ar investigation therapeutic agents for treatment of patients World Health Organization ar severely sick from COVID-19. Teaming up with Targeted Pharmaceutical opened the door to a collaboration with a prestigious USA science lab at the American Revolutionary leader University. Having the power to review investigational new medication in animals World Health Organization are infected with the COVID-19 virus may be a major chance for the United States. The analysis team can gain tremendous data on the role of a protein unharness modulating drug plays in COVID-19 infections. this sort of animal analysis was wont to study potential drug candidates for Near East metastasis Syndrome (MERS-CoV) and last the REGN-COV2 protein in SARS-CoV-2 infected animals. the corporate isn't creating any expressed or silent claims that its product has the power to eliminate, cure, and/or contain the COVID-19 or the SARS-COV-2 virus at now. "

Source: GlobalData.com